Evidence map›Paper›PMID 26842481›Full record

ArticleJournal of virology2016

Promoter-Targeted Histone Acetylation of Chromatinized Parvoviral Genome Is Essential for the Progress of Infection.

Elina Mäntylä, Kari Salokas, Mikko Oittinen, Vesa Aho, Pekka Mäntysaari, Lassi Palmujoki, Olli Kalliolinna, Teemu O Ihalainen, Einari A Niskanen, Jussi Timonen and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Elina MäntyläDepartment of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla, Finland.
Kari SalokasDepartment of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla, Finland.
Mikko OittinenTampere Center for Child Health Research, University of Tampere, Tampere, Finland.
Vesa AhoDepartment of Physics and Nanoscience Center, University of Jyvaskyla, Jyvaskyla, Finland.
Pekka MäntysaariDepartment of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla, Finland.
Lassi PalmujokiDepartment of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla, Finland.
Olli KalliolinnaDepartment of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla, Finland.
Teemu O IhalainenNeuroGroup, BioMediTech, University of Tampere, Tampere, Finland.
Einari A NiskanenInstitute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Jussi TimonenDepartment of Physics and Nanoscience Center, University of Jyvaskyla, Jyvaskyla, Finland.
Keijo ViiriTampere Center for Child Health Research, University of Tampere, Tampere, Finland keijo.viiri@uta.fi maija.vihinen-ranta@jyu.fi.
Maija Vihinen-RantaDepartment of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla, Finland keijo.viiri@uta.fi maija.vihinen-ranta@jyu.fi.ORCID http://orcid.org/0000-0003-0959-1153
University of Jyväskylä · FITampere University · FIUniversity of Eastern Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledThe association of host histones with parvoviral DNA is poorly understood. We analyzed the chromatinization and histone acetylation of canine parvovirus DNA during infection by confocal imaging andin situproximity ligation assay combined with chromatin immunoprecipitation and high-throughput sequencing. We found that during late infection, parvovirus replication bodies were rich in histones bearing modifications characteristic of transcriptionally active chromatin, i.e., histone H3 lysine 27 acetylation (H3K27ac). H3K27ac, in particular, was located in close proximity to the viral DNA-binding protein NS1. Importantly, our results show for the first time that in the chromatinized parvoviral genome, the two viral promoters in particular were rich in H3K27ac. Histone acetyltransferase (HAT) inhibitors efficiently interfered with the expression of viral proteins and infection progress. Altogether, our data suggest that the acetylation of histones on parvoviral DNA is essential for viral gene expression and the completion of the viral life cycle. IMPORTANCE: Viral DNA introduced into cell nuclei is exposed to cellular responses to foreign DNA, including chromatinization and epigenetic silencing, both of which determine the outcome of infection. How the incoming parvovirus resists cellular epigenetic downregulation of its genes is not understood. Here, the critical role of epigenetic modifications in the regulation of parvovirus infection was demonstrated. We showed for the first time that a successful parvovirus infection is characterized by the deposition of nucleosomes with active histone acetylation on the viral promoter areas. The results provide new insights into the regulation of parvoviral gene expression, which is an important aspect of the development of parvovirus-based virotherapy.

Indexed as

Genome, ViralPromoter Regions, GeneticAcetylationAnimalsCatsCell LineChromatinDNA, ViralEpigenesis, GeneticGene Expression Regulation, ViralHistonesLysineMicroscopy, ConfocalParvoviridae InfectionsParvovirus, CanineVirus IntegrationChromatinDNA, ViralHistonesLysine

Identifiers

PMID26842481
PMCPMC4810569
OpenAlexW2313682627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.